Rational design of a targeted theranostic nanoagent for sequential application during oral squamous cell carcinoma surgery

Key Points

• The research aims to design a targeted theranostic nanoagent that assists in the surgical removal of oral squamous cell carcinoma (OSCC).
• Developing a nanoagent for imaging and treatment.
• Testing the nanoagent in preclinical models.
• Assessing its efficacy in aiding tumor removal during surgery.
• The nanoagent successfully identified tumor margins.
• Significantly improved the rate of complete tumor removal during simulated surgeries.